Hexim Pharmaceuticals, Laboratoires Bailleul, Sinclair IS Pharma sales and marketing update

Sinclair said it divested non-core products Effederm, Xclair, Salinum and Numoisyn ( SST) for £1.1 million ($1.8 million) in cash. Laboratoires Bailleul acquired acne treatment Effederm, which had...